Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Eli Lilly & Co (LLY)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Eli Lilly & Co.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 59478.
Total stock buying since 2015: $8,218,370.
Total stock sales since 2015: $23,196,371,694.
Total stock option exercises since 2015: $14,061,172.
Table 3. Detailed insider trading at Eli Lilly & Co (LLY) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-02-01 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 10,244 | .00 | 0 |
| 2017-02-01 | Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) | Option Ex | 10,244 | .00 | 0 |
| 2017-02-01 | Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) | Option Ex | 5,634 | .00 | 0 |
| 2017-02-01 | Mahony Susan (SVP & Pres., Lilly Oncology) | Option Ex | 9,732 | .00 | 0 |
| 2017-02-01 | Rice Derica W (EVP-Global Services and CFO) | Option Ex | 19,463 | .00 | 0 |
| 2017-02-01 | Lechleiter John C | Option Ex | 46,097 | .00 | 0 |
| 2017-02-01 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 77.69 | 17,091,360 |
| 2016-12-16 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Sale | 2,093 | 82.23 | 172,107 |
| 2016-12-16 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,000 | 72.13 | 72,130 |
| 2016-12-16 | Mahony Susan (SVP & Pres., Lilly Oncology) | Sale | 20,242 | 72.67 | 1,470,884 |
| 2016-12-16 | Hoover R David | Buy | 500 | 71.85 | 35,925 |
| 2016-12-16 | Tai Jackson P | Buy | 1,375 | 72.64 | 99,880 |
| 2016-12-16 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 72.69 | 14,538,200 |
| 2016-10-05 | Crowe Maria A (President, Mfg. Operations) | Sale | 1,835 | 81.43 | 149,424 |
| 2016-10-04 | Crowe Maria A (President, Mfg. Operations) | Sale | 413 | 81.12 | 33,502 |
| 2016-10-03 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 18,350 | .00 | 0 |
| 2016-10-02 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 3,894 | .00 | 0 |
| 2016-10-02 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 4,130 | .00 | 0 |
| 2016-10-02 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 3,760 | .00 | 0 |
| 2016-08-31 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 6,556 | .00 | 0 |
| 2016-08-12 | Tai Jackson P | Buy | 2,560 | 80.42 | 205,875 |
| 2016-08-03 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 7,500 | .00 | 0 |
| 2016-07-29 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 82.94 | 17,001,880 |
| 2016-07-28 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,213 | 83.16 | 100,873 |
| 2016-07-28 | Lilly Endowment Inc (10% Owner) | Sale | 240,000 | 82.97 | 19,913,280 |
| 2016-07-12 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 79.54 | 16,703,820 |
| 2016-07-07 | Lilly Endowment Inc (10% Owner) | Sale | 225,000 | 79.41 | 17,867,250 |
| 2016-06-30 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 78.37 | 16,849,120 |
| 2016-06-29 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 77.89 | 17,135,800 |
| 2016-06-10 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Sale | 992 | 73.77 | 73,179 |
| 2016-05-31 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 75.12 | 15,023,200 |
| 2016-05-12 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 76.22 | 14,481,990 |
| 2016-04-29 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 75.77 | 13,638,960 |
| 2016-04-08 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 74.29 | 14,857,800 |
| 2016-02-05 | Fry Stephen F (SVP, HR & Diversity) | Sale | 15,230 | 78.87 | 1,201,190 |
| 2016-02-03 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Sale | 2,460 | 76.73 | 188,755 |
| 2016-02-03 | Fry Stephen F (SVP, HR & Diversity) | Sale | 725 | 76.46 | 55,433 |
| 2016-02-03 | Rice Derica W (EVP-Global Services and CFO) | Sale | 3,937 | 76.81 | 302,400 |
| 2016-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 2,072 | .00 | 0 |
| 2016-02-01 | Harrington Michael J (Senior VP and General Counsel) | Option Ex | 9,066 | .00 | 0 |
| 2016-02-01 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Sale | 3,273 | 78.36 | 256,472 |
| 2016-02-01 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Option Ex | 9,843 | .00 | 0 |
| 2016-02-01 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 7,252 | .00 | 0 |
| 2016-02-01 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 4,144 | .00 | 0 |
| 2016-02-01 | Fry Stephen F (SVP, HR & Diversity) | Sale | 2,412 | 78.39 | 189,076 |
| 2016-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 7,252 | .00 | 0 |
| 2016-02-01 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Option Ex | 15,541 | .00 | 0 |
| 2016-02-01 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 9,843 | .00 | 0 |
| 2016-02-01 | Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) | Option Ex | 10,360 | .00 | 0 |
| 2016-02-01 | Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) | Option Ex | 5,698 | .00 | 0 |
| 2016-02-01 | Mahony Susan (SVP & Pres., Lilly Oncology) | Option Ex | 9,843 | .00 | 0 |
| 2016-02-01 | Rice Derica W (EVP-Global Services and CFO) | Sale | 6,546 | 78.36 | 512,944 |
| 2016-02-01 | Rice Derica W (EVP-Global Services and CFO) | Option Ex | 19,685 | .00 | 0 |
| 2016-02-01 | Lechleiter John C (Chairman, President and CEO) | Option Ex | 46,623 | .00 | 0 |
| 2016-02-01 | Tai Jackson P | Buy | 3,170 | 78.62 | 249,225 |
| 2016-01-29 | Zulueta Alfonso G (SVP& Pres., Emerging Markets) | Sale | 5,000 | 78.75 | 393,750 |
| 2015-12-21 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 86.00 | 17,630,000 |
| 2015-12-15 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 85.59 | 18,402,925 |
| 2015-12-09 | Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) | Sale | 25,000 | 83.88 | 2,097,000 |
| 2015-12-02 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 85.23 | 17,897,670 |
| 2015-11-23 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 9,036 | 56.18 | 507,642 |
| 2015-11-20 | Zulueta Alfonso G (SVP& Pres., Emerging Markets) | Option Ex | 12,048 | 56.18 | 676,856 |
| 2015-11-20 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 84.89 | 17,403,475 |
| 2015-11-12 | Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) | Option Ex | 6,928 | 56.18 | 389,215 |
| 2015-11-05 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Option Ex | 4,970 | 56.18 | 279,214 |
| 2015-11-03 | Lechleiter John C (Chairman, President and CEO) | Option Ex | 70,964 | 56.18 | 3,986,757 |
| 2015-10-29 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 82.63 | 16,525,800 |
| 2015-10-09 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 86.14 | 18,520,100 |
| 2015-10-05 | Lilly Endowment Inc (10% Owner) | Sale | 260,000 | 86.98 | 22,616,100 |
| 2015-09-18 | Lilly Endowment Inc (10% Owner) | Sale | 250,000 | 89.29 | 22,322,500 |
| 2015-07-28 | Mahony Susan (SVP & Pres., Lilly Oncology) | Sale | 25,000 | 84.96 | 2,124,000 |
| 2015-06-10 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 82.78 | 17,383,380 |
| 2015-06-04 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 78.20 | 15,640,799 |
| 2015-06-01 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 79.36 | 17,460,080 |
| 2015-05-29 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 200 | 78.33 | 15,666 |
| 2015-05-29 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Sale | 20,000 | 78.08 | 1,561,600 |
| 2015-05-20 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 73.43 | 13,951,320 |
| 2015-05-15 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 72.83 | 14,566,399 |
| 2015-05-08 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 73.28 | 14,289,795 |
| 2015-05-05 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 6,024 | 56.18 | 338,428 |
| 2015-05-05 | Rice Derica W (EVP-Global Services and CFO) | Option Ex | 57,108 | 54.36 | 3,104,390 |
| 2015-05-01 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 73.09 | 14,617,599 |
| 2015-04-28 | Harrington Michael J (Senior VP and General Counsel) | Option Ex | 6,024 | 56.18 | 338,428 |
| 2015-04-28 | Lechleiter John C (Chairman, President and CEO) | Option Ex | 70,000 | 56.18 | 3,932,600 |
| 2015-03-30 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 73.94 | 13,308,660 |
| 2015-03-23 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 77.17 | 14,661,730 |
| 2015-03-09 | Fry Stephen F (SVP, HR & Diversity) | Sale | 4,000 | 69.27 | 277,080 |
| 2015-02-11 | Mahony Susan (SVP & Pres., Lilly Oncology) | Option Ex | 9,036 | 56.18 | 507,642 |
| 2015-02-05 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 374 | 71.03 | 26,565 |
| 2015-02-04 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Sale | 3,147 | 69.99 | 220,258 |
| 2015-02-04 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Sale | 11,085 | 70.08 | 776,836 |
| 2015-02-04 | Rice Derica W (EVP-Global Services and CFO) | Sale | 5,316 | 70.00 | 372,120 |
| 2015-02-03 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Sale | 71,711 | 70.72 | 5,071,401 |
| 2015-02-02 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Sale | 4,769 | 71.51 | 341,031 |
| 2015-02-02 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Sale | 50,000 | 70.87 | 3,543,500 |
| 2015-02-02 | Rice Derica W (EVP-Global Services and CFO) | Sale | 10,068 | 71.84 | 723,285 |
| 2015-02-01 | Ricks David A (SVP and Pres, Lilly Bio-Meds) | Option Ex | 12,591 | .00 | 0 |
| 2015-02-01 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 9,094 | .00 | 0 |
| 2015-02-01 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 5,246 | .00 | 0 |
| 2015-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 8,394 | .00 | 0 |
| 2015-02-01 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Option Ex | 20,985 | .00 | 0 |
| 2015-02-01 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 12,591 | .00 | 0 |
| 2015-02-01 | Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) | Option Ex | 13,990 | .00 | 0 |
| 2015-02-01 | Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) | Option Ex | 6,995 | .00 | 0 |
| 2015-02-01 | Mahony Susan (SVP & Pres., Lilly Oncology) | Option Ex | 12,591 | .00 | 0 |
| 2015-02-01 | Rice Derica W (EVP-Global Services and CFO) | Option Ex | 26,581 | .00 | 0 |
| 2015-02-01 | Lechleiter John C (Chairman, President and CEO) | Option Ex | 52,462 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of LLY listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Eli Lilly & Co (symbol LLY,
CIK number 59478) see
the Securities and Exchange Commission (SEC) website.